¥29.06 ($4.34)

+0.81 (+2.87%)

SHH · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 68 · ¥13.5B mcap · 298M float · 2.94% daily turnover

Revenue

$7.2B -15.8% ▼

5Y CAGR: +6.4%

Gross Profit

$2.4B -23.5% ▼

5Y CAGR: +2.8%

Operating Income

-$273M -136.0% ▼

Net Income

-$381M -159.3% ▼

EPS (Diluted)

$-0.82 -159.4% ▼

EBITDA

$258M -70.2% ▼

5Y CAGR: -18.0%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$8.2B	$11.9B	$15.5B	$8.5B	$7.2B
YoY Growth	+56.4%	+44.9%	+29.6%	-44.8%	-15.8%
Cost of Revenue	$4.4B	$6.3B	$8.8B	$5.4B	$4.8B
Gross Profit	$3.8B	$5.6B	$6.7B	$3.1B	$2.4B
Gross Margin	46.7%	47.3%	43.1%	36.5%	33.1%
R&D Expenses	$397M	$518M	$633M	$467M	$400M
SG&A Expenses	$1.5B	$2.3B	$2.5B	$1.7B	$1.5B
Operating Expenses	$2.0B	$2.9B	$3.3B	$2.4B	$2.7B
Operating Income	$1.8B	$2.8B	$3.3B	$760M	-$273M
Operating Margin	22.0%	23.2%	21.6%	8.9%	-3.8%
Interest Expense	$31M	$30M	$27M	$24M	$21M
Income Before Tax	$1.8B	$2.7B	$3.3B	$740M	-$439M
Tax Expense	$237M	$384M	$476M	$103M	-$24M
Net Income	$1.5B	$2.2B	$2.8B	$643M	-$381M
Net Margin	18.3%	18.6%	17.8%	7.5%	-5.3%
EPS (Diluted)	$3.27	$4.76	$5.89	$1.38	$-0.82
EBITDA	$2.1B	$3.1B	$3.7B	$867M	$258M
Shares Outstanding	462M	466M	467M	466M	465M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.7B	$1.6B	$1.5B	$1.5B	$1.5B	$1.5B	$1.4B	$1.5B
Cost of Revenue	$1.1B	$1.2B	$979M	$1.0B	$978M	$977M	$880M	$946M
Gross Profit	$626M	$408M	$488M	$529M	$563M	$515M	$471M	$587M
Gross Margin	36.0%	26.0%	33.2%	34.6%	36.5%	34.5%	34.9%	38.3%
R&D Expenses	$106M	$98M	$77M	$84M	$82M	$98M	$74M	$83M
SG&A Expenses	$408M	$368M	$354M	$341M	$439M	-$487M	$334M	$331M
Operating Expenses	$618M	$791M	$524M	$599M	$525M	$582M	$405M	$385M
Operating Income	$8M	-$383M	-$36M	-$70M	$38M	-$67M	$66M	$202M
Operating Margin	0.5%	-24.4%	-2.5%	-4.6%	2.5%	-4.5%	4.9%	13.2%
Interest Expense	$5M	$4M	$4M	$4M	$4M	$3M	$3M	$3M
Income Before Tax	-$936K	-$535M	-$37M	-$72M	$27M	-$99M	$61M	$196M
Tax Expense	-$2M	-$36M	-$3M	-$10M	$19M	-$10M	$13M	$33M
Net Income	$4M	-$475M	-$28M	-$57M	$5M	-$94M	$43M	$147M
Net Margin	0.2%	-30.2%	-1.9%	-3.7%	0.3%	-6.3%	3.2%	9.6%
EPS (Diluted)	$0.01	$-1.03	$-0.06	$-0.12	$0.01	$-0.20	$0.09	$0.32
EBITDA	$111M	-$151M	$69M	-$6M	$31M	$26M	$64M	$199M
Shares Outstanding	463M	463M	463M	463M	463M	463M	475M	461M

603882.SS SHH